Recently, blockade of granulocyte-macrophage colony-stimulating factor (GM-CSF) has been shown to effectively suppress myeloid cell activity in rheumatoid arthritis patients and thus may be also an interesting treatment option for patients with general low disease activity but persistent strong macrophage infiltration in the affected joint27,28. This evidence concerns the gene CSF2 and rheumatoid arthritis.